VirTra (VTSI) Q2 2025 earnings summary

Executive summary

• Q2 2025 revenue increased 15% year-over-year to $7 million, with six-month revenue up 5% to $14.14 million, driven by higher capital deliveries and stable recurring revenue.

• Net income for Q2 was $0.2 million, down 85% year-over-year, and $1.4 million for the first six months, reflecting margin pressure from higher costs and sales mix.

• Gross margin declined to 69% in Q2 2025 from 91% in Q2 2024 due to a higher mix of capital sales and normalization of COGS classification.

• Bookings for Q2 were $4.6 million, backlog at June 30 was $18.8 million, and STEP recurring revenue program maintained a 95% renewal rate with more three-year agreements.

• Working capital was robust at $34.1 million, and the company maintained a debt-light balance sheet with $20.7 million in cash and equivalents.

Financial highlights

• Q2 2025 revenue: $7 million (up 15% year-over-year); six months: $14.14 million (up 5%).

• Q2 gross profit: $4.8 million (69% margin), down from $5.5 million (91%) last year; net income: $0.2 million ($0.02 per share), down from $1.2 million ($0.10 per share).

• Adjusted EBITDA for Q2 was $0.7 million; six-month Adjusted EBITDA was $2.4 million, both down year-over-year.

• Net operating expense for Q2 was $3.9 million, down 11% year-over-year, reflecting disciplined cost management.

• Cash and cash equivalents at June 30, 2025: $20.7 million; working capital: $34.1 million.

Outlook and guidance

• Management expects improved order activity as federal funding conditions strengthen, with most new capital bookings from H1 expected to convert to revenue in 2025, though some may extend into 2026.

• Updated STEP program with three-year commitments and 95%+ renewal rates enhances recurring revenue visibility and long-term growth prospects.

• Current capital resources are expected to support operations for more than 12 months; management is open to raising additional funds if needed.